EVALUATION OF THE SAFETY AND REACTOGENICITY OF THE COMBINED VACCINE PENTAXIM
- Authors: KHARIT S.М.1, IOZEFOVICH O.V1, RULEVA A.A1, FRIDMAN I.V1, KRAYNOVA T.I1
-
Affiliations:
- Issue: No 2 (2017)
- Pages: 62-66
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/278593
- ID: 278593
Cite item
Abstract
Full Text
About the authors
Susanna М. KHARIT
Email: kharit-s@mail.ru
Pediatric Research and Clinical Center for Infectious Diseases, Federal Biomedical Agency of Russia Saint Petersburg State Pediatric Medical University Saint Petersburg, Russia
O. V IOZEFOVICH
Email: olia004@yandex.ru
Pediatric Research and Clinical Center for Infectious Diseases, Federal Biomedical Agency of Russia Saint Petersburg, Russia
A. A RULEVA
Email: ruleanna@yandex.ru
Pediatric Research and Clinical Center for Infectious Diseases, Federal Biomedical Agency of Russia Saint Petersburg State Pediatric Medical University Saint Petersburg, Russia
I. V FRIDMAN
Email: fridiv@mail.ru
Pediatric Research and Clinical Center for Infectious Diseases, Federal Biomedical Agency of Russia Saint Petersburg, Russia
T. I KRAYNOVA
Email: epidnadzor@78.rospotrebnadzor.ru
Directorate for Saint Petersburg, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare Saint Petersburg, Russia
References
- Report from the SAGE Working Group on Pertussis vaccines, 26-27 August 2014 meeting. Geneva, Switzerland. http://www. who.int/immunization/sage/meetings/2015/april/1_Pertussis_ report_fmal.pdf?ua=1; accessed July 2015.
- Weekly Epidemiological Record, Pertussis vaccines: WHO position paper 28 August 2015, №. 35. 2015; 90: 433-60. http://www.who. int/wer
- de Celle M.D., Magpantay F.M.G., King A.A., Rohani P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc. R. Soc. B 283: 20152309. http://dx.doi.org/10.1098/ rspb.2015.2309
- Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2014 году». Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека; 2015. http://rospotrebnadzor.ru/documents/details. php?ELEMENT_ID=3692 [State report «On the state sanitary and epidemiological wellbeing of the population in the Russian Federation in 2014». Federal service for supervision of consumer rights protection and human welfare; 2015]. http://rospotrebnadzor.ru/documents/details. php?ELEMENT_ID=3692 (In Russ.).
- Jefferson T., Rudin M., DiPietrantonj C. Systematic review of the effects ofpertussis vaccines in children. Vaccine 2003; 21: 2003-14.
- Borba R.C.N., Vidal V. M., Moreira I. The re-emergency and persistence of vaccine preventable diseases Annals of the Brazilian Academy of Sciences 2015; 87(Suppl. 2): 1311-22.
- Carlsson R., Trollfors B. Control of pertussis - lessons learnt from a 10-year surveillance programme in Sweden. Vaccine 2009; 27: 5709-18.
- Okada K., Ohashi Y., Matsuo F., Uno S., Soh M., Nishima S. Effectiveness of an acellular pertussis vaccine in Japanese children during a non-epidemic period: a matched case-control study. Epidemiol. Infect. 2009; 137(1): 124-30.
- Radke S., Petousis-Harris H., Watson D. et al. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand. Vaccine 2017; 35: 177-83.
- Zhang L., Prietsch S., Axelsson I., Halperin S.A. Acellular vaccines for preventing whooping cough in children. The Cochrane database of systematic reviews 2014; 9: CD001478.
- Offit P., Quarles J., Gerber M., Hackett C.J., Marcuse E.K., Kollman T.R., Bruce G., Landry S. Addressing parents’ concerns: Do multiple vaccines overwhelm or weaken the infant’s immune system? Pediatrics 2002; 109(1): 124-9. DOI: 10.1542/ peds.109.1.124.